InnovaRx Innova Health Strategies

S41.112S

Laceration without foreign body of left upper arm, sequela

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 8 never code together
S41code
Excludes1
  • traumatic amputation of shoulder and upper arm (S48.-)S48.-
Excludes2
  • open fracture of shoulder and upper arm (S42.- with 7th character B or C)S42.-
S40-S49block
Excludes2
  • burns and corrosions (T20-T32)T20-T32
  • frostbite (T33-T34)T33-T34
  • injuries of elbow (S50-S59)S50-S59
  • insect bite or sting, venomous (T63.4)T63.4
S00-T88chapter
Excludes2

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

7th character 3
A initial encounter
D subsequent encounter
S sequela this code
Instructional notes 6
S41code
Code also
  • any associated wound infection
S40-S49block
Includes
  • injuries of axilla
  • injuries of scapular region
S00-T88chapter
Notes
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
Use additional code
  • code to identify any retained foreign body, if applicable (Z18.-)Z18.-
Index entries leading here 1
  • Laceration
Alongside this code 2 same parent — S41.112
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
S41.112
Block
S40-S49
Siblings
2

Present FY2024–FY2027.